Medtronic’s (NYSE:MDT) Microstream capnography (CO2) and Invos regional oximetry (rSO2) platforms can now be integrated with GE Healthcare’s Carescape.
The two companies announced today that they received FDA clearance and CE mark approval for the integration of Medtronic’s Microstream and Invos technologies for perioperative and ICU care on the GE Healthcare Carescape precision monitoring platform.
According to a news release, the regulatory nods complete the full suite of Medtronic patient monitoring solutions available on the Carestream system, with the combined offering also featuring GE Healthcare FlexAcuity to give clinicians the ability to choose care options based on patient acuity needs and assist in earlier detection of patient deterioration.
Dr. Eva Masso Lago, an anesthesiologist with Germans Trias I. Pujol Hospital in Barcelona, Spain, who uses Carescape and Invos monitors, said in the release that integrating the Medtronic technology to GE’s platform will “add ergonomic benefits, enhance ease of use and improve workflow.”
“Our longstanding collaboration with Medtronic allows GE Healthcare to integrate clinically advanced parameters to enable clinicians with precision monitoring for individualized care,” GE Healthcare GM for Monitoring Solutions Neal Sandy said in the release. “We are able to add these capabilities to both new and existing enterprise monitoring systems, ensuring clinicians have access to real-time, reliable patient insights that can play a critical role in care decisions and outcomes.”
Invos rSO2 technology monitors for signs of hemodynamic changes and deteriorating patient conditions associated with cerebral desaturation events. Microstream CO2 technology offers early indications of patient decline and is validated for neonatal to adult patients to use a proprietary CO2-specific infrared wavelength that is highly accurate and unaffected by the presence of other gases. It also utilizes Smart Capnography algorithms engineered to enhance patient safety, improve clinical workflow and ease alarm fatigue.
“Medtronic and GE Healthcare are both committed to expanding access to patient care around the world,” Medtronic President of Patient Monitoring Frank Chan said. “This collaboration brings together our combined medical technology leadership to improve workflow, allowing clinicians more time to focus on what matters most – the patient. Together, we are empowering clinicians with actionable insights to personalize care.”
The two companies have a longstanding relationship, including a collaboration announced in April that focuses on the growing need for outpatient care. The partnership, centered around the needs and demand for care at ambulatory surgery centers (ASCs) and office-based labs (OBLs), aims to offer customers access to extensive product portfolios, financial solutions and other services.
